ABBOTT LABORATORIES 흥망사

ABBOTT LABORATORIES ABT

출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD

검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)

재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음

✦ 흥망사

버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.

▾ 데이터 표 보기

연도	매출	영업이익	순이익	자산	부채	FCF	영업이익률	매출 YoY
2007	$25.9B	$4.6B	—	$39.7B	—	—	17.7%	—
2008	$29.5B	$5.7B	—	$42.4B	—	—	19.3%	▲ 13.9%
2009	$30.8B	$6.2B	—	$52.6B	—	—	20.3%	▲ 4.2%
2010	$35.2B	$6.1B	—	$60.6B	—	—	17.3%	▲ 14.3%
2011	$21.4B	$1.6B	$4.7B	$60.3B	—	$7.5B	7.6%	▼ 39.1%
2012	$19.1B	$1.4B	$6B	$67.2B	—	$7.5B	7.1%	▼ 11.0%
2013	$19.7B	$2.1B	$2.6B	$42.9B	—	$2.2B	10.9%	▲ 3.2%
2014	$20.2B	$2.6B	$2.3B	$41.2B	—	$2.6B	12.8%	▲ 3.0%
2015	$20.4B	$2.9B	$4.4B	$41.2B	—	$1.9B	14.1%	▲ 0.8%
2016	$20.9B	$3B	$1.4B	$52.7B	—	$2.1B	14.5%	▲ 2.2%
2017	$27.4B	$1.6B	$477M	$76.3B	—	$4.4B	5.7%	▲ 31.3%
2018	$30.6B	$3.7B	$2.4B	$67.2B	—	$4.9B	11.9%	▲ 11.6%
2019	$31.9B	$4.5B	$3.7B	$67.9B	—	$4.5B	14.2%	▲ 4.3%
2020	$34.6B	$5.4B	$4.5B	$72.5B	—	$5.7B	15.5%	▲ 8.5%
2021	$43.1B	$8.4B	$7.1B	$75.2B	—	$8.6B	19.6%	▲ 24.5%
2022	$43.7B	$8.4B	$6.9B	$74.4B	—	$7.8B	19.2%	▲ 1.3%
2023	$40.1B	$6.5B	$5.7B	$73.2B	—	$5.1B	16.2%	▼ 8.1%
2024	$42B	$6.8B	$13.4B	$81.4B	—	$6.4B	16.3%	▲ 4.6%
2025	$44.3B	$8.1B	$6.5B	$86.7B	—	$7.4B	18.2%	▲ 5.7%